Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762253 · ClinicalTrials.gov registry record · Phase 2
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
A Phase 2 study, sponsored by Nvision Laser Eye Centers.
- Terminated
- Registry status
- Phase 2
- Development phase
- 320
- Enrollment target
NCT02762253: Clinical Trial Phase 2 study, sponsored by Nvision Laser Eye Centers.
NCT02762253 is a Phase 2 study that was terminated before completion, run by Nvision Laser Eye Centers. The registered enrollment target is 320 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (141% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02762253, a Phase 2 study, was terminated before completion, sponsored by Nvision Laser Eye Centers.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 320 participants
- Enrollment target
Study Summary
This study is being conducted to assess the safety and effectiveness of photochemically induced collagen cross- linking (CCL) at irradiance of 18mW/cm2 in eyes with Keratoconus and Ecstasia.
Primary Outcome
The change in maximum keratometry (Kmax) from baseline will be evaluated at 6 months for all eyes. Data will be summarized using descriptive statistics.
Interventions
- DRUG Riboflavin drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Why NCT02762253 stopped before completion
NCT02762253 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (141% higher).
The record links to 0 conditions, and to 1 intervention - of which Riboflavin drops is the first listed.
NCT02762253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02762253 about?
NCT02762253 is a clinical study titled "Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.". This study is being conducted to assess the safety and effectiveness of photochemically induced collagen cross- linking (CCL) at irradiance of 18mW/cm2 in eyes with Keratoconus and Ecstasia.
What is the current status of trial NCT02762253?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 320 participants. The study started on 2012-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02762253?
The interventions under investigation include: Riboflavin drops (DRUG).
Who is sponsoring clinical trial NCT02762253?
This trial is sponsored by Nvision Laser Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02762253's enrollment target sits among peer trials
320 152nd of 2000 higher than 1,848 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia